SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018835
Filing Date
2023-05-08
Accepted
2023-05-08 16:19:24
Documents
77
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20230331.htm   iXBRL 10-Q 3208731
2 EX-10.1 pcvx-ex10_1.htm EX-10 255839
3 EX-31.1 pcvx-ex31_1.htm EX-31 17369
4 EX-31.2 pcvx-ex31_2.htm EX-31 17656
5 EX-32.1 pcvx-ex32_1.htm EX-32 8038
  Complete submission text file 0000950170-23-018835.txt   11232396

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20230331_def.xml EX-101.DEF 252052
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20230331.xsd EX-101.SCH 72400
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20230331_lab.xml EX-101.LAB 525606
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20230331_pre.xml EX-101.PRE 420570
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20230331_cal.xml EX-101.CAL 52320
71 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20230331_htm.xml XML 2103513
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 23898039
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences